VARGATEF < sup > ® < /sup > plus docetaxel significantly reduced tumour burden in lung cancer patients with advanced adenocarcinoma compared to docetaxel alone
VARGATEF < sup > ® < /sup > plus docetaxel significantly reduced tumour burden in lung cancer patients with advanced adenocarcinoma compared to docetaxel alone
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Docetaxel | Lung Cancer | Research | Taxotere